European Business Magazine says oral Wegovy has 1.5 million patients and about $843m in first-half sales, while semaglutide generics spread in India and Canada.
Recap by typeshit. Full story at European Business Magazine.
Women on CagriSema hit 20% weight loss far more often than on semaglutide alone, 68.7% vs 38.0%, though Novo calls the comparisons exploratory.
The Sugarfit co-founder and the doctor argue that managing weight on GLP-1 medications takes more than the drug by itself.
Rooney says the Ozempic rumors are wrong, that he is working to look better and be healthier, and that he has stopped drinking alcohol for a while.
An investor take on Indian contract manufacturers: the argument is that spending on plants for peptides, ADCs and oligos matters more than concall buzz.
In a Healio Eye-Mail brief, she gives her view on a review of a possible link between GLP-1 medications and NAION, a type of optic nerve damage.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
Loading…